Curemark

Curemark is a drug research and development company focused on the treatment of neurological and other diseases especially those with dysautonomic components by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr.  Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about Curemark's innovative science, visit www.curemark.com.